This is a StreetInsider.com Premium Only Page

Chelsea Therapeutics (CHTP) – Company Press Releases

Jun 19, 2014 04:30 PM NORTHERA(TM) Clinical Trial Data Published in Neurology

Jun 12, 2014 07:30 AM Chelsea Therapeutics Presents Efficacy and Safety Data for NORTHERA at International Congress of Parkinson's Disease and Movement Disorders

Jun 6, 2014 07:00 AM Chelsea Therapeutics Announces the Expiration of the Hart-Scott-Rodino Waiting Period in Relation to the Proposed Acquisition of Chelsea Therapeutics by Lundbeck

May 8, 2014 07:58 AM Chelsea Therapeutics to Host Conference Call to Discuss Acquisition by Lundbeck

May 8, 2014 07:54 AM Lundbeck to Acquire Chelsea Therapeutics

Mar 11, 2014 04:25 PM Chelsea Therapeutics Reports Fourth Quarter and Full-Year 2013 Results

Feb 28, 2014 07:00 AM Chelsea Therapeutics Joins NORD in Promoting Awareness for Rare Disease Day

Jan 27, 2014 07:00 AM Chelsea Therapeutics Announces Joseph G. Oliveto Named President and Chief Executive Officer, Director

Jan 14, 2014 05:09 PM FDA Advisory Panel Recommends Approval of Chelsea Therapeutics' NORTHERA(TM) (Droxidopa) for the Treatment of Symptomatic nOH

Dec 9, 2013 07:00 AM Chelsea Therapeutics Announces First Patient Dosed in NORTHERA(TM) (droxidopa) Study 401 for the Treatment of Symptomatic nOH